Fibrolamellar Carcinoma - 4 Studies Found

Recruiting : A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
:
  • Advanced Adult Hepatocellular Carcinoma
  • Advanced Fibrolamellar Carcino
    : 2014-09-05
    : Drug: ENMD-2076 250 mg oral dose, QD for 28 day cycles
Active, not recruiting : Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
:
  • Fibrolamellar Carcinoma
  • Fibrolamellar Liver Cancer

: 2012-07-12
:
  • Drug: everolimus
  • Drug: letrozole plus leup
Terminated : Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
:
  • Hepatocellular Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
    : 2010-09-24
    : Drug: Sutent Sunitinib 50mg/day (per os) for 6 cycles duration of one cycle = 6 weeks (4 weeks of treatm
Recruiting : Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
:
  • Fibrolamellar Hepatocellular Carcinoma
  • Hepatocellular Carcinoma
    : 2016-02-26
    :
    • Procedure: living related donor partial liver transplantation